CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 1 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 37.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,984 | -18.1% | 925 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,307 | +105.2% | 925 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $3,561 | +24.6% | 925 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $2,858 | -28.6% | 925 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $4,000 | -20.0% | 925 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $5,000 | -37.5% | 925 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $8,000 | +60.0% | 925 | +131.2% | 0.00% | +100.0% |
| Q4 2021 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |